fbpx

New Partner joins Lundbeckfonden Emerge

Andreas Jurgeit is to join Lundbeckfonden Emerge, the early stage investment unit of the Lundbeck Foundation, as a partner on 1 January 2019.

Andreas has been active in various operational and financing roles over the last decade. He was first exposed to biotech as a scientist collaborating with 3V Biosciences during his PhD and later joined Zurich-based venture investor Redalpine as Investment Manager. Most recently, as Director of the Merck Ventures Life Science team, he has conducted investments globally, with portfolio companies and board mandates in Europe, the US and Israel.

Andreas is 37 years old and is originally from Austria. He holds degrees in Molecular Biology from the University of Innsbruck and a PhD in Virology from the University of Zurich.

News

An untreated throat infection can turn into a fatal bacterial cluster bomb
19. June 2019
The Lundbeck Foundation gives grants worth DKK 97 million to young scientists
7. June 2019
Milk teeth tell of a population undiscovered for over 30,000 years
6. June 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge